Stay updated with breaking news from Stem Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Stem (NYSE:STEM – Free Report) had its target price decreased by BMO Capital Markets from $2.50 to $1.85 in a research note released on Friday morning, Benzinga reports. BMO Capital Markets currently has a market perform rating on the stock. Several other brokerages have also weighed in on STEM. TD Cowen dropped their price objective […]
Pennsylvania-headquartered Helius Medical Technologies, Inc. (HSDT) is up over 51% in Friday's pre-market trading. The following are some of the other stocks making big moves in Friday's pre-market trading.
Substantial increase of +42% CARR-to-ARR conversion since January 2024 Introducing Next Generation Asset Performance Management Software Suite Reaffirming Full Year 2024 Operating Cash Flow,...